cbdMD (YCBD) Shares Outstanding (Diluted Average) (2018 - 2025)
cbdMD's (YCBD) quarterly Shares Outstanding (Diluted Average) came in at $4.0 million in Q3 2025, up 646.22% year-on-year from $539069.0 in Q3 2024, and up 646.22% quarter-over-quarter from $539069.0 in Q3 2024.
cbdMD (YCBD) Shares Outstanding (Diluted Average) (2018 - 2025) Analysis & Trends
cbdMD has disclosed Shares Outstanding (Diluted Average) across 8 years of filings, most recently posting $4.0 million for Q3 2025.
- Shares Outstanding (Diluted Average) for Q3 2025 came in at $4.0 million, up 646.22% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.0 million (up 646.22% YoY), and the FY2025 annual result was $4.0 million, up 646.22% from the prior year.
- Shares Outstanding (Diluted Average) came in at $4.0 million for Q3 2025 at cbdMD, up from $539069.0 in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $61.4 million in Q2 2021 to a low of $539069.0 in Q3 2024.
- The 5-year median for Shares Outstanding (Diluted Average) is $2.7 million (2023), against an average of $21.8 million.
- Across the five-year window, Shares Outstanding (Diluted Average) tumbled 97.85% in 2022 and jumped 646.22% in 2025, its largest moves.
- cbdMD's Shares Outstanding (Diluted Average) stood at $57.8 million in 2021, then climbed by 4.38% to $60.4 million in 2022, then tumbled by 96.65% to $2.0 million in 2023, then sank by 73.34% to $539069.0 in 2024, then surged by 646.22% to $4.0 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $4.0 million (Q3 2025), $539069.0 (Q3 2024), and $3.0 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | cbdMD | 3,884.57 | -3.38 Mn | 3.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.02 Mn |
| Sep 30, 2024 | 539,069.00 |
| Mar 31, 2024 | 2.96 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 60.36 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 57.83 Mn |
| Sep 30, 2021 | 54.94 Mn |
| Jun 30, 2021 | 61.43 Mn |
| Mar 31, 2021 | 52.79 Mn |
| Dec 31, 2020 | 52.13 Mn |
| Sep 30, 2020 | 45.17 Mn |
| Jun 30, 2020 | 42.53 Mn |
| Mar 31, 2020 | 37.34 Mn |
| Dec 31, 2019 | 28.55 Mn |
| Sep 30, 2019 | 17.89 Mn |